Table 4 Arbitrary selection of trials investigating cost per quality-adjusted life year for a variety of interventions in the critically ill and in non-ICU patients
Critically ill | Costs per quality-adjusted life year |
|---|---|
Hamel, et al. (2000) [36] | Low-risk group (likelihood of surviving 2 months, >70%): 28,889 € |
Mechanical ventilation for acute respiratory failure due to pneumonia or Adult Respiratory Distress Syndrome versus mechanical ventilation withheld | Medium-risk group (likelihood of surviving 2 months, 51% to 70%): 43,832 € |
High-risk group (likelihood of surviving 2 months, <50%): 109,582 € | |
Hamel, et al. (1997) [37] | Average costs: 143,742 € |
Initiating dialysis and continuing aggressive care in seriously ill patients versus withholding renal support therapy | Best prognostic category: 69,404 € |
Worst prognostic category: 307,329 € | |
Paniagua, et al. (2002) [38] | Quality of life estimated: 84,365 € |
Cardiopulmonary resuscitation for in-hospital cardiac arrest in octogenarians followed by aggressive treatment | |
Non-ICU patients | |
CDC Diabetes Cost-effectiveness Group (2002) [39] | Intensive glycemic control: 42,463 € |
Reducing complications in patients with type 2 diabetes using various interventions | Reducing serum cholesterol level: 53,242 € |
Intensified hypertension control saves 2,010 € | |
Wonderling, et al. (2004) [40] | 13,311 € |
Acupuncture for chronic headache in primary care versus usual care only | |
Brunner-La Rocca, et al. (2007) [41] | 40,467 € |
Drug-eluting stents versus bare-metal stents in percutaneous coronary interventions |